[Brief history of the development of valproate in bipolar disorders].

No abstract is available for this paper.

• Publication year

  2001

• Venue

  L'Encephale

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 11686059
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of sodium valproate on mania

  2004cited by this paper
• Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.

  2000cited by this paper
• Low-dose lithium augmentation of divalproex in geriatric mania.

  2000cited by this paper
• Comprehensive review of the psychiatric uses of valproate.

  2000cited by this paper
• Increase in serum clomipramine concentrations caused by valproate.

  2000cited by this paper
• A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.

  2000cited by this paper
• Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania.

  1999cited by this paper
• Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients.

  1999cited by this paper
• Efficacy of lithium vs. valproate in the treatment of mania in the elderly: a retrospective study.

  1999cited by this paper
• Mood stabilizer combinations: a review of safety and efficacy.

  1998cited by this paper
• Lithium Plus Valproate as Maintenance Polypharmacy for Patients With Bipolar I Disorder: A Review

  1998cited by this paper
• Treatment algorithm use to optimize management of symptomatic patients with a history of mania.

  1998cited by this paper
• The Efficacy and Use of Anticonvulsants in Mood Disorders

  1998cited by this paper
• Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder.

  1997cited by this paper
• A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder.

  1997cited by this paper
• Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium.

  1996cited by this paper
• Relation of serum valproate concentration to response in mania.

  1996cited by this paper
• Valproate as an antidepressant in major depressive disorder.

  1996cited by this paper
• Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: a case series.

  1996cited by this paper
• Trends in pharmacotherapy of Schizoaffective and bipolar affective disorders: a 5-year naturalistic study.

  1996cited by this paper
• A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.

  1996cited by this paper
• New Concepts in Mood Stabilization: Evidence for the Effectiveness of Valproate and Lamotrigine

  1996cited by this paper
• Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.

  1995cited by this paper
• A clinically significant interaction between clozapine and valproate.

  1995cited by this paper
• Predictors of response to divalproex and lithium.

  1995cited by this paper
• History of the development of valproate for treatment of bipolar disorder.

  1995cited by this paper
• Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders.

  1994cited by this paper
• Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.

  1994cited by this paper
• Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.

  1994cited by this paper
• Divalproex sodium in the treatment of refractory affective disorders.

  1993cited by this paper
• The effect of valproate on bipolar spectrum temperamental disorders.

  1993cited by this paper
• Treatment of Rapid Cycling Bipolar Disorder with Combination Therapy of Valproate and Lithium

  1993cited by this paper
• Valproate oral loading in the treatment of acute mania.

  1993cited by this paper
• Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.

  1993cited by this paper
• Predictors of valproate response in bipolar rapid cycling.

  1993cited by this paper
• Clinical Experience with Valproic Acid in 22 Patients with Refractory Bipolar Mood Disorder

  1992cited by this paper
• Synergy of carbamazepine and valproic acid in affective illness: case report and review of the literature.

  1992cited by this paper
• A double-blind comparison of valproate and lithium in the treatment of acute mania.

  1992cited by this paper
• Valproate in the treatment of acute mania. A placebo-controlled study.

  1991cited by this paper
• Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder.

  1990cited by this paper
• Valproate use in the older manic patient.

  1990cited by this paper
• U.S. experience with valproate in manic depressive illness: a multicenter trial.

  1989cited by this paper
• Long-term use of valproate in primary psychiatric disorders.

  1989cited by this paper
• Valproate in the treatment of rapid-cycling bipolar disorder.

  1988cited by this paper
• The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders.

  1985cited by this paper
• Valproic acid amide as a prophylactic agent in affective and schizoaffective disorders.

  1984cited by this paper
• Lithium as a prophylactic agents. Its effect against recurrent depressions and manic-depressive psychosis.

  1967cited by this paper

• Brief intervention reduces prescription of sodium valproate in women of childbearing age

  2023cites this paper
• Bipolar Disorder and Manic-Like Symptoms in Alzheimer’s, Vascular and Frontotemporal Dementia: A Systematic Review

  2022cites this paper
• Valproate, divalproex, valpromide: Are the differences in indications justified?

  2022cites this paper
• Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors

  2022cites this paper
• Valproate-associated Movement Disorder: A Literature Review.

  2021influential citation
• Mood Stabilizers in Psychiatric Disorders and Mechanisms Learnt from In Vitro Model Systems

  2021cites this paper
• Anticonvulsants for Mental Disorders: Valproate, Lamotrigine, Carbamazepine and Oxcarbazepine

  2020cites this paper
• Lessons learned from the discovery of sodium valproate and what has this meant to future drug discovery efforts?

  2020cites this paper
• Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit

  2020cites this paper
• Harnessing Drug Repurposing for Exploration of New Diseases: An Insight to Strategies and Case Studies.

  2020cites this paper
• Valproate-Associated Isolated Serum Creatine Kinase Elevation.

  2020cites this paper
• The promise and challenges of drug repurposing in psychiatry

  2018cites this paper
• All guns blazing: management and survival of massive valproic acid overdose – case report and literature review

  2018cites this paper
• Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis

  2016cites this paper
• Does indication drive use, or does use drive indication?

  2015cites this paper
• Review of Sodium Valproate Clinical and Biochemical Properties

  2015cites this paper
• Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research.

  2015cites this paper
• Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012

  2013cites this paper
• Comparison of the Usefulness of Lithium and Valproate

  2013cites this paper
• Non-Fatal and Fatal Liver Failure Associated with Valproic Acid

  2012cites this paper
• Activation of suicidal ideation with adjunctive rufinamide in bipolar disorder.

  2011cites this paper
• [Relationship between plasma concentrations of valproic acid and hepatotoxicity in patients receiving high doses].

  2011cites this paper
• Pharmacological treatment of bipolar disorder among children and adolescents

  2007cites this paper
• Valproate overdose: a comparative cohort study of self poisonings.

  2003cites this paper
• Search for a common mechanism of mood stabilizers.

  2003cites this paper
• Mood stabilizer psychopharmacology.

  2002cites this paper